*Some Market data delayed by 15 mins.

Nurix Therapeutics, Inc. Common stock

Symbol: NRIX (NASDAQ)
21.28 ▼ (-2.26%) -0.491

Company Description:
Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies. Its drug candidate from E3 ligase inhibitor portfolio, NX-1607, is an orally available CBL-B inhibitor for immuno-oncology indications.

Key Stats
  • Today's Open: $21.81
  • Today's High: $22.505
  • Today's Low: $20.801
  • Today's Volume: 705.52K
  • Yesterday Close: $21.77
  • Yesterday High: $23.07
  • Yesterday Low: $21.49
  • Yesterday Volume: 902.58K
  • Last Min Volume: 0
  • Last Min High: $21.279
  • Last Min Low: $21.255
  • Last Min VWAP: $0
Company Profile
  • Name: Nurix Therapeutics, Inc. Common stock
  • Website: http://www.nurixtx.com
  • Listed Date: 2020-07-24
  • Location: SAN FRANCISCO, CA
  • Market Status: Active
  • CIK Number: 0001549595
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $1.36B
  • Round Lot: 100
  • Outstanding Shares: 64.41M
  • Asset Type: CS
RECENT FILINGS FOR NRIX
Filing DateFiling TypeFormat
2024-07-184View
2024-07-11424B5View
2024-07-1110-QView
2024-07-118-KView
2024-07-014View
2024-07-01144View
2024-06-204View
2024-06-20144View
2024-06-178-KView
2024-06-134View
2024-06-124View
2024-06-11S-3ASRView
2024-06-07SC 13G/AView
2024-06-054View
2024-06-034View
2024-06-03144View
2024-05-218-KView
2024-05-204View
2024-05-204View
2024-05-204View
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.